Innoviva (INVA) Free Cash Flow (2010 - 2026)
Innoviva (INVA) posted Free Cash Flow of $34.8 million for Q1 2026, down 75.38% on a QoQ basis from $141.3 million in Q3 2025, and down 28.44% year-over-year from $48.6 million in Q1 2025.
Innoviva (INVA) Free Cash Flow (2010 - 2026) Analysis & Trends
Innoviva's Free Cash Flow history runs 17 years deep, the most recent figure standing at $34.8 million for Q1 2026.
- Quarterly Free Cash Flow fell 28.44% year-over-year to $34.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220.2 million (down 0.61% YoY) and the FY2025 annual result came in at $195.8 million, up 3.92% from the prior year.
- Free Cash Flow was $34.8 million for Q1 2026 at Innoviva, down from $141.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $192.8 million in Q3 2022 and bottomed at $25.7 million in Q1 2023.
- A 5-year average of $78.5 million and a median of $48.6 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 73.85% — and 2024, when it jumped 44.43%.
- Innoviva's Free Cash Flow stood at $192.8 million in 2022, then slumped by 44.22% to $107.5 million in 2023, then gained by 20.11% to $129.2 million in 2024, then climbed by 9.38% to $141.3 million in 2025, then slumped by 75.38% to $34.8 million in 2026.
- Business Quant data shows INVA's Free Cash Flow at $34.8 million in Q1 2026, $141.3 million in Q3 2025, and $44.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 34.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.79 Mn |
| Mar 31, 2026 | 34.79 Mn |
| Sep 30, 2025 | 141.30 Mn |
| Sep 30, 2025 | 141.30 Mn |
| Jun 30, 2025 | 44.07 Mn |
| Jun 30, 2025 | 44.07 Mn |
| Mar 31, 2025 | 48.62 Mn |
| Mar 31, 2025 | 48.62 Mn |
| Sep 30, 2024 | 129.18 Mn |
| Sep 30, 2024 | 129.18 Mn |
| Jun 30, 2024 | 43.72 Mn |
| Jun 30, 2024 | 43.72 Mn |
| Mar 31, 2024 | 37.05 Mn |
| Mar 31, 2024 | 37.05 Mn |
| Sep 30, 2023 | 107.55 Mn |
| Sep 30, 2023 | 107.55 Mn |
| Jun 30, 2023 | 38.18 Mn |
| Jun 30, 2023 | 38.18 Mn |
| Mar 31, 2023 | 25.65 Mn |
| Mar 31, 2023 | 25.65 Mn |